Form 4: UnitedHealth Group CEO Stephen Hemsley Reports Acquisition of Dividend Equivalents

UnitedHealth Group's CEO and Director, Stephen J. Hemsley, reported the acquisition of 55 shares of common stock as dividend equivalents on vested deferred stock units, effective June 24, 2025, under a Rule 10b5-1 plan.

Summary

• Stephen J. Hemsley, CEO and Director of UnitedHealth Group Inc. (UNH), reported a transaction involving the company's common stock.
• On June 24, 2025, Hemsley acquired 55 shares of common stock.
• These shares represent dividend equivalents paid on vested deferred stock units and were acquired at a price of $0, indicating they were not purchased but granted as part of compensation.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, signifying a pre-arranged trading plan.
• Following this transaction, Hemsley's direct beneficial ownership of common stock is 374,407.942 shares.
• Indirect beneficial ownership includes 347.29 shares via a 401(k) and 735,115 shares via Trusts.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled acquisition of shares as part of executive compensation, which is generally neutral to slightly positive as it increases executive alignment with shareholders. No negative implications are present.

Positives

• The acquisition of shares, even as dividend equivalents, increases the executive's stake in the company, aligning their interests with shareholders.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary transaction, which is viewed positively for transparency and mitigating insider trading concerns.

Risks

• This document, an SEC Form 4, reports an insider stock transaction and does not contain information regarding company-specific operational, financial, or strategic risks. The risks inherent to holding company stock are general market risks, not specific to this filing.

Future Outlook

This Form 4 filing reports a specific transaction related to executive compensation and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details an individual executive's stock transaction and does not provide broader industry context or trends. It is a routine disclosure of insider ownership changes within the healthcare services sector.

Comparison to Industry Standards

• This document is an insider trading report (Form 4) and does not contain information suitable for comparison to industry-wide financial or operational benchmarks. It solely reports a specific executive's stock acquisition.

Corporate Governance

Related Party Transactions

• The document reports an acquisition of shares by a key executive, which is inherently a related party transaction. No other distinct related party dealings or disclosures are detailed within this filing.

Stakeholder Impact

• Shareholders: The acquisition of additional shares by a key executive, even as dividend equivalents, slightly increases management's alignment with shareholder interests.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• This Form 4 reports a completed transaction and does not outline specific future actions or milestones for the company or the reporting person beyond the ongoing nature of their stock ownership.

Key Dates

Keywords

UnitedHealth Group, UNH, Stephen J. Hemsley, SEC Form 4, Insider Trading, Dividend Equivalents, Deferred Stock Units, Executive Compensation, Rule 10b5-1